AI note-taking tool Abridge transforms patient care at Chicago hospital
CHICAGO, UNITED STATES — The University of Chicago Medicine is significantly expanding its use of Abridge, a generative artificial intelligence (GenAI) platform designed for clinical documentation, to over 800 clinicians within its health system.
This decision follows a successful six-week pilot program involving 200 physicians, which demonstrated notable improvements in patient and clinician experiences.
Abridge’s technology efficiently converts real-time patient-clinician conversations into structured clinical notes, integrating seamlessly with electronic medical records (EMRs). This capability enhances clinical efficiency and communication, making it an essential tool for healthcare providers.
Pilot program success: Improved patient and clinician satisfaction
During the pilot phase, UChicago Medicine observed measurable improvements in patient satisfaction according to Press Ganey surveys:
- A 4.4 percentage point increase in “concern shown by the provider.”
- A 3.6-point rise in satisfaction with “explanations about the patient’s problem or condition.”
- A 3.0-point improvement in patients feeling “included in care decisions.”
Clinicians also reported significant benefits:
- 90% felt more valued by UChicago Medicine after using Abridge.
- The ability of clinicians to provide undivided attention to patients increased from 49% to 90%.
Abridge’s leadership in healthcare AI
Abridge has been recognized as a leading emerging technology by KLAS, ranking highly for improving clinician and patient experiences as well as outcomes.
The platform is already utilized by prominent healthcare systems such as Mayo Clinic, University of Pittsburgh Medical Center (UPMC), and Yale New Haven Health.
Its recent $150 million Series C funding round, supported by NVIDIA, further underscores its growing influence in the healthcare AI sector.
